Medical Devices Growth Capital Investments in 2021
Acquisition Volume in Medical Devices Growth Capital Investments in 2021 by Year
Last 5 years
-
December 23, 2021
- Buyer
- Hayfin Capital Management LLP, Gyrus Capital
- Target
- Corcym
- Industry
- Medical Devices
- Location
- England, United Kingdom
- Type
- Growth capital
Corcym, a global medical device company focused on structural heart solutions, closed a €45 million growth financing arranged by funds managed by Hayfin Capital Management. The financing (preferred equity plus a senior credit facility) will support Corcym's international expansion and strategic growth initiatives alongside existing investor Gyrus Capital.
-
December 9, 2021
- Buyer
- GHO Capital Partners LLP, Excellere Partners
- Target
- Biocare Medical
- Industry
- Medical Devices
- Location
- California, United States
- Type
- Growth capital
London-based GHO Capital has invested in Biocare Medical, a California-headquartered developer of immunohistochemistry reagents and diagnostic instrumentation, alongside existing investor Excellere Partners. The capital will be used to accelerate R&D, expand the instrument offering, and support international expansion to capture growing demand for oncology diagnostics.
-
December 8, 2021
- Buyer
- EQT Private Equity (EQT IX)
- Target
- 3Shape
- Seller
- Founders of 3Shape
- Industry
- Medical Devices
- Location
- Denmark
- Type
- Growth capital
EQT Private Equity (via the EQT IX fund) agreed to acquire a 20% minority stake in Copenhagen-based digital dentistry leader 3Shape from the company's founders, who remain majority shareholders. The investment will provide growth capital and access to EQT's digitalization and global healthcare expertise to accelerate 3Shape's international expansion and roll-out of additional digital services.
-
December 3, 2021
- Buyer
- Carlyle
- Target
- Resonetics
- Industry
- Medical Devices
- Location
- New Hampshire, United States
- Type
- Growth capital
Funds managed by Carlyle have acquired a significant minority equity stake in Resonetics, valuing the specialized medical device contract manufacturer at approximately $2.25 billion. Carlyle will join existing investor GTCR as a meaningful shareholder while Sverica retains a minority position; the investment will support Resonetics’ continued organic growth, international expansion and add-on acquisition strategy.
-
October 19, 2021
- Buyer
- LLR Partners
- Target
- Genesee Scientific
- Industry
- Medical Devices
- Location
- California, United States
- Type
- Growth capital
LLR Partners completed a growth investment in Genesee Scientific, a San Diego–based manufacturer and distributor of life-science consumables and laboratory equipment. The partnership will fund expansion of Genesee's product portfolio and scaling of its national footprint; Audax Private Debt provided unitranche financing to support the transaction.
-
- Buyer
- CPS Capital, PharmaSmart management (existing management team)
- Target
- PharmaSmart International
- Industry
- Medical Devices
- Location
- New York, United States
- Type
- Growth capital
Toronto-based private equity firm CPS Capital made a strategic growth investment in PharmaSmart International alongside the company’s existing management team. The financing (which included term debt from FirePower Capital and Nicola Wealth) will fund roll‑out of PharmaSmart’s PS-2000D health kiosk platform and accelerate expansion across Canada and the United States.
-
June 15, 2021
- Buyer
- Private investor clients of Connection Capital
- Target
- MatOrtho Ltd
- Seller
- MatOrtho shareholders
- Industry
- Medical Devices
- Location
- Surrey, United Kingdom
- Type
- Growth capital
Private investor clients of Connection Capital have invested £6.75 million in MatOrtho to support international expansion and product development. MatOrtho, based in Leatherhead, designs and manufactures orthopaedic implant devices and will use the funding to accelerate market growth and R&D; Simon Cartmell has joined the board as a Non-Executive.
-
- Buyer
- Confluent Medical Technologies Inc.
- Target
- The Electrospinning Company Ltd.
- Industry
- Medical Devices
- Location
- England, United Kingdom
- Type
- Growth capital
Confluent Medical Technologies made a strategic minority investment in The Electrospinning Company Ltd to access its proprietary electrospinning process and expand design/manufacturing options for the transcatheter structural heart market. The investment aims to combine Confluent's Nitinol and biomedical textile expertise with Electrospinning's nanofiber biomaterials capability and to automate the application of textiles to valve frames.
-
March 18, 2021
- Buyer
- Ampersand Capital Partners
- Target
- Magritek
- Industry
- Medical Devices
- Location
- Wellington, New Zealand
- Type
- Growth capital
Ampersand Capital Partners made a minority growth investment in Magritek, a New Zealand-based maker of benchtop and portable NMR instruments. The investment will support Magritek's product expansion and market growth (including flow chemistry and bioprocess monitoring) while leveraging Ampersand's healthcare-focused private equity expertise.
-
January 26, 2021
- Buyer
- Granite Creek Capital Partners, L.L.C.
- Target
- Life Spine, Inc.
- Industry
- Medical Devices
- Location
- Illinois, United States
- Type
- Growth capital
Granite Creek Capital Partners, a Chicago-based private investment firm, announced a growth investment in Life Spine, Inc., a Huntley, Illinois-based medical device company that develops spinal implant solutions. The minority institutional capital raise (from Granite Creek’s FlexCap II fund) will support Life Spine’s commercial expansion and product development; Granite Creek partner Mark Radzik will join Life Spine’s board.
-
January 25, 2021
- Buyer
- Public Pension Capital
- Target
- Life Science Outsourcing, Inc.
- Industry
- Medical Devices
- Location
- California, United States
- Type
- Growth capital
Public Pension Capital, a New York-based private equity fund, made an investment in Life Science Outsourcing, Inc., a Brea, California-based contract manufacturer serving medical device companies. The transaction, completed January 25, 2021, will support LSO's medical package testing, validation, sterilization and distribution services and help accelerate the company's growth and capacity to serve device startups and larger OEMs.
-
January 12, 2021
- Buyer
- SHS Gesellschaft für Beteiligungsmanagement mbH
- Target
- Blue Ocean Spine GmbH
- Industry
- Medical Devices
- Location
- Baden-Württemberg, Germany
- Type
- Growth capital
SHS Gesellschaft für Beteiligungsmanagement (SHS) is the lead investor in Blue Ocean Spine GmbH, a Tuttlingen, Germany-based developer of functional spinal implants that uses additive manufacturing. The investment will support product development, manufacturing scale-up and regulatory activities as Blue Ocean Spine advances next-generation expandable and anchor-equipped cage implants and targets future U.S. FDA approval.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.